A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells-Reference-Cited by-同舟云学术

A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells

Published:2016-11-18 Issue:12 Volume:13 Page:4222-4230
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Beloqui Ana¹,Alhouayek Mireille²,Carradori Dario¹,Vanvarenberg Kevin¹,Muccioli Giulio G.²,Cani Patrice D.³,Préat Véronique¹

Affiliation:

1. Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, 1200 Brussels, Belgium

2. Université catholique de Louvain, Louvain Drug Research Institute, Bioanalysis and Pharmacology of Bioactive Lipids Group, 1200 Brussels, Belgium

3. Université catholique de Louvain, WELBIO (Walloon Excellence in Life sciences and BIOtechnology), Louvain Drug Research Institute, Metabolism and Nutrition Group, 1200 Brussels, Belgium

Funder

European Research Council

Fonds De La Recherche Scientifique - FNRS

Artois-Baillet Latour Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b00871

Reference40 articles.

1. Glucose Sensing in L Cells: A Primary Cell Study

2. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract

3. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery

4. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

5. Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut hormone stimulation as a therapeutic approach in oral peptide delivery;Journal of Controlled Release;2024-09

2. A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment;Journal of Drug Delivery Science and Technology;2024-05

3. A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment;Bioactive Materials;2024-02

4. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery;Journal of Controlled Release;2023-11

5. The application of nanomedicine in clinical settings;Frontiers in Bioengineering and Biotechnology;2023-06-27